Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Front Mol Neurosci 15:829642 Eilmez OK, Aksoy F, Kalcioglu MT, Steyger PS (2024) Ototoxicity: cochleotoxicity and vestibulotoxicity
Batch verification lookup when lots are published Quality standards target purity vs lot purity Order request ask about documentation timing Format Lyophilized powder, single vial Strength 10 mg Supplier-listed target 99% (HPLC) not a lot-specific result Appearance White lyophilized powder Solubility Aqueous laboratory solvents (method-dependent
Read Our Blog and discover the main variables that affect health economics and outcomes research (HEOR) project costs
These include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Vomiting (common, affecting up to 1 in 10 people) Constipation (common) Abdominal pain (common) Dyspepsia (indigestion) These gastrointestinal symptoms typically occur during dose initiation or escalation and often diminish over time as the body adjusts to the medication
The investigative team flags this as a significant concern, particularly given the likelihood that demand will continue to increase and that many patients may need to use these medications indefinitely
